E&C Lets CMS Exempt Long-Term Care Pharmacies From Lock-In, But Facilities Want More
Long-term care pharmacies are pleased that House Energy & Commerce members opened the door to exempting them from the pharmacy lock-in plan in 21st Century Cures legislation, but they prefer to be excluded outright. The third ‘Cures’ draft, which cleared the health subcommittee Thursday (May 14), includes new language suggesting CMS consider exempting long-term care facility residents from the measure that lets plans limit which pharmacies may dispense drugs prone to abuse, such as pain medicine.
The latest version of the bill also codifies that hospice patients are exempt from the so-called lock-in restrictions and lets CMS exempt other categories of individuals as well.
“The bill can and should be further strengthened by making clear that beneficiaries in skilled nursing facilities and other long-term care settings are exempt by legislation rather than subsequent administrative rule,” said Alan Rosenbloom, president of Senior Care Pharmacy Coalition, which represents independent long-term care pharmacies.
Still, he said the revisions are a “significant step in the right direction” because they recognize some beneficiaries should not be covered by the provision because they already are protected by rules governing the facilities that serve them. Rosenbloom told Inside Health Policy that long-term care pharmacies already are subject to regulations stricter than those that would be applied to so-called safe pharmacy networks.
While the primary goal of the Cures bill is to speed approvals of breakthrough drugs and medical devices, the committee has long been concerned with abuse of prescription drugs and plans to talk with state health officials about the problem next week.
Seniors’ advocates and long-term care pharmacies support drug-abuse prevention, but they worry the pharmacy lock-in measure in the Cure’s legislation would make it difficult for beneficiaries to obtain vital medicine.
The second draft added a beneficiary-appeals measure, but lobbyists for seniors and long-term care pharmacies said that was insufficient. While the third draft went a step further by exempting hospice patients and suggesting CMS consider exempting long-term care facility residents and others, long-term care pharmacies are still worried they could get snagged by the restrictions. — John Wilkerson (jwilkerson@iwpnews.com)
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.